MacroGenics
MGNX
#9151
Rank
A$0.16 B
Marketcap
A$2.63
Share price
-5.18%
Change (1 day)
-46.18%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07180. In 2024 the company made an earnings per share (EPS) of A-$1.54 a decrease over its 2023 EPS that were of A-$0.22.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.11%
2024A-$1.54613.33%
2023A-$0.22-92.31%
2022A-$2.80-42.14%
2021A-$4.8436.44%
2020A-$3.55-21.84%
2019A-$4.54-24.58%
2018A-$6.02675.93%
2017A-$0.78-68.05%
2016A-$2.43168.25%
2015A-$0.90-55%
2014A-$2.013400%
2013A-$0.05744-108.68%
2012A$0.6624.49%
2011A$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.47-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$29.46-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$18.71-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.36-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.90-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.26-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.54 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA